Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Adma Biologics (ADMA) Shares Issued (2016 - 2025)

Historic Shares Issued for Adma Biologics (ADMA) over the last 11 years, with Q3 2025 value amounting to $389000.0.

  • Adma Biologics' Shares Issued fell 9316.46% to $389000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 5754.36%. This contributed to the annual value of $7.5 million for FY2024, which is 57880.43% up from last year.
  • Per Adma Biologics' latest filing, its Shares Issued stood at $389000.0 for Q3 2025, which was down 9316.46% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Shares Issued registered a high of $64.6 million during Q4 2022, and its lowest value of $8000.0 during Q4 2023.
  • Over the past 5 years, Adma Biologics' median Shares Issued value was $1.0 million (recorded in 2024), while the average stood at $13.1 million.
  • As far as peak fluctuations go, Adma Biologics' Shares Issued crashed by 9998.76% in 2023, and later soared by 543750.0% in 2024.
  • Over the past 5 years, Adma Biologics' Shares Issued (Quarter) stood at $53.8 million in 2021, then rose by 20.09% to $64.6 million in 2022, then plummeted by 99.99% to $8000.0 in 2023, then soared by 5437.5% to $443000.0 in 2024, then dropped by 12.19% to $389000.0 in 2025.
  • Its Shares Issued stands at $389000.0 for Q3 2025, versus $2.1 million for Q2 2025 and $101000.0 for Q1 2025.